Drug Shortage Report for TAMIFLU
Report ID | 105912 |
Drug Identification Number | 02381842 |
Brand name | TAMIFLU |
Common or Proper name | Oseltamivir Phosphate |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OSELTAMIVIR |
Strength(s) | 6MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 100 mL glass bottles with a bottle adapter and 1 oral dispenser |
ATC code | J05AH |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-03-01 |
Actual start date | 2020-03-10 |
Estimated end date | 2020-03-31 |
Actual end date | 2020-04-20 |
Shortage status | Resolved |
Updated date | 2020-04-21 |
Company comments | Roche will manage the supply of current inventory until the end of February. We anticipate availability of new stock by the end of March. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-04-21 | English | Compare |
v8 | 2020-04-20 | French | Compare |
v7 | 2020-04-20 | English | Compare |
v6 | 2020-03-11 | English | Compare |
v5 | 2020-03-10 | French | Compare |
v4 | 2020-03-10 | English | Compare |
v3 | 2020-03-02 | English | Compare |
v2 | 2020-02-13 | French | Compare |
v1 | 2020-02-13 | English | Compare |
Showing 1 to 9 of 9